Novel Phenethylamines as 5‑HT2A Agonists for Treating Depression, Drug Addiction, Alcoholism, PTSD, and Neuropathic Pain. [PDF]
Sabnis RW.
europepmc +1 more source
Soft Independent Modeling of Class Analogies for the Screening of New Psychoactive Substances through UPLC-HRMS/MS. [PDF]
Bracaglia I +8 more
europepmc +1 more source
Self-Reported Adverse Effects Associated With New Psychoactive Substance Use in a Sample of Adults From 20 US Cities. [PDF]
Fitzgerald ND, Palamar JJ, Cottler LB.
europepmc +1 more source
The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents. [PDF]
Nadal-Gratacós N +22 more
europepmc +1 more source
Explainable Artificial Intelligence (xAI) for 5-HT<sub>2A</sub> Receptor Binding Affinity of New Psychoactive Substances. [PDF]
Schöning V +5 more
europepmc +1 more source
TUSI Valve: Echocardiographic and Pathologic Correlates of a Novel Drug-Induced Valvular Disease-a Case Series. [PDF]
Vasquez-Rodriguez JF +9 more
europepmc +1 more source
Nickel-photoredox catalysis: merging photons with metal catalysts for organic synthesis. [PDF]
Manzoor F +9 more
europepmc +1 more source
The Epidemiology of Recreational Use and Availability of DOC and DOI in the United States. [PDF]
Palamar JJ, Fitzgerald ND.
europepmc +1 more source
Cardiac blood phenethylamine as a potential biomarker for post-mortem interval in forensic autopsy cases. [PDF]
Nara A +4 more
europepmc +1 more source
The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects. [PDF]
Luethi D +14 more
europepmc +1 more source

